Tandem Diabetes Care (NASDAQ:TNDM) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Tandem Diabetes Care missed estimated earnings by 21.15%, reporting an EPS of $-0.63 versus an estimate of $-0.52.
Revenue was down $6.52 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 4.69% drop in the share price the next day.
Here’s a look at Tandem Diabetes Care’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.06 | -0.05 | 0.02 | -0.07 |
| EPS Actual | -0.01 | -0.27 | -0.24 | -0.23 |
| Revenue Estimate | 221.83M | 208.16M | 205.20M | 168.43M |
| Revenue Actual | 220.50M | 204.55M | 200.26M | 175.91M |
To track all earnings releases for Tandem Diabetes Care visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
